Login to Your Account



Financings roundup


Tuesday, February 18, 2014
Regimmune Corp., of Tokyo, closed a series D financing of $9.2 million, with the round led by Japan Asia Investment Corp. and Nippon Venture Capital Corp.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription